Skip to main content

A broad host-range Acinetobacter baumannii phage and its novel glycan receptor

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-07-14

About This Grant

PROJECT SUMMARY Acinetobacter baumannii (Ab) is a highly antibiotic resistant opportunistic pathogen that is a major source of hospital acquired infections. To combat its growing burden, there is an urgent need to find alternative methods of treatment, such as the use of bacteriophages (phages), termed phage therapy. Phage therapy has been used in isolated compassionate use cases of recalcitrant Acinetobacter infections, but is limited by the exquisitely narrow host range of most Ab phages. This narrow host range is in large part due to the highly variable capsule that occludes most phages from accessing the cell. Each phage typically carries a highly specialized capsule binding and depolymerase protein able to bind to and degrade a single capsule type. However, we recently isolated a broad host range Acinetobacter phage that attaches to an uncharacterized glycan that is accessible even when capsule is present. The glycan that the phage attaches to, which we have termed phage glycan receptor (PGR), was previously unknown even though it is found in almost all pathogenic Acinetobacter strains. The phage, termed StAb3, is also almost entirely uncharacterized, belonging to an unclassified taxon with few other phage relatives. StAb3 can infect about 90% of Ab strains, although it can only replicate efficiently in a subset of them. Combined, the discoveries of PGR and StAb3 present a unique opportunity to uncover fundamental biology while also advancing phage therapy or phage-derived therapeutics. To this end, we will investigate the structure and biosynthesis of PGR as well as its role in adherence and pathogenesis. In parallel, we will dissect the molecular interaction between the phage binding protein and PGR, as well as determine why even when this phage can infect most strains, it is often not able to replicate well. This study has the potential to transform the landscape of phage therapy and reveal unexplored aspects of Ab biology.

Grant Summary

A broad host-range Acinetobacter baumannii phage and its novel glycan receptor is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $428K for university, nonprofit, healthcare org. Applications are due 2028-05-31 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $428K

Deadline

2028-05-31

Complexity
Medium
  1. 1Confirm your organization is eligible for A broad host-range Acinetobacter baumannii phage and its novel glycan receptor from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

A broad host-range Acinetobacter baumannii phage and its novel glycan receptor: Frequently Asked Questions

Who is eligible for the A broad host-range Acinetobacter baumannii phage and its novel glycan receptor?

A broad host-range Acinetobacter baumannii phage and its novel glycan receptor is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the A broad host-range Acinetobacter baumannii phage and its novel glycan receptor provide?

A broad host-range Acinetobacter baumannii phage and its novel glycan receptor provides up to $428K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the A broad host-range Acinetobacter baumannii phage and its novel glycan receptor deadline?

Applications for A broad host-range Acinetobacter baumannii phage and its novel glycan receptor are due 2028-05-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the A broad host-range Acinetobacter baumannii phage and its novel glycan receptor?

To apply for A broad host-range Acinetobacter baumannii phage and its novel glycan receptor, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.